QuickView for C-FMS;jsessionid=C3573561C82F2633AC01D5B18CDE5741;jsessionid=ACB2848E354C9F687DC57AC0223D0315;jsessionid=53DC49513944772B42A143E0FC147D8E;jsessionid=BB3DD3BD0F973BBB82111F7A2317BB78;jsessionid=98E21648149A9C019F0919DC2D6736D8 (gene)

1. CSF1R inhibitors are emerging immunotherapeutic drugs for cancer treatment.
2. A highly selective purine-based inhibitor of CSF1R potently inhibits osteoclast differentiation.
3. Engineering an inhibitor-resistant human CSF1R variant for microglia replacement.
4. A kinase-dead Csf1r mutation associated with adult-onset leukoencephalopathy has a dominant inhibito…
5. CSF1R inhibitors induce a sex-specific resilient microglial phenotype and functional rescue in a tau…

There were no clinical trials for C-FMS;jsessionid=C3573561C82F2633AC01D5B18CDE5741;jsessionid=ACB2848E354C9F687DC57AC0223D0315;jsessionid=53DC49513944772B42A143E0FC147D8E;jsessionid=BB3DD3BD0F973BBB82111F7A2317BB78;jsessionid=98E21648149A9C019F0919DC2D6736D8